| Title |
Author |
Type |
Date |
Words |
| Draft NICE Guidance for Aggressive non-Hodgkin Lymphoma Treatment, PIXUVRI (pixantrone). |
|
|
Apr 10, 2013 |
1696 |
| German Institute for Quality and Efficiency in Health Care (IQWiG) Publishes Dossier Evaluation within Early Benefit Assessment Process of PIXUVRI (pixantrone). |
|
|
Mar 1, 2013 |
1579 |
| Health Canada Approves ADCETRIS[R] (Brentuximab Vedotin) for the Treatment of Relapsed or Refractory Hodgkin Lymphoma (HL) and Systemic Anaplastic Large Cell Lymphoma (sALCL). |
|
|
Feb 1, 2013 |
1301 |
| Preclinical Study Provides Potential Mechanisms for Lower Cardiotoxicity in Patients with Multiply Relapsed or Refractory Aggressive B-cell NHL Treated with PixuvriTM Who Received Prior Doxorubicin Therapy. |
|
|
Dec 17, 2012 |
1332 |
| New Results add to Growing Body of Evidence That Support Bendamustine-rituximab (B-R) Combination as First-Line Treatment in Patients With Indolent non-Hodgkin (iNHL) and Mantle Cell Lymphomas (MCL). |
|
|
Dec 11, 2012 |
2243 |
| Seattle Genetics Reports Data from Phase I Trial of ADCETRIS[R] (Brentuximab Vedotin) in Front-line Mature T-Cell Lymphomas (MTCL). |
|
|
Dec 9, 2012 |
2103 |
| Spectrum Pharmaceuticals Provides Update on Belinostat Registrational Trial for the Treatment of Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL). |
|
|
Sep 24, 2012 |
2247 |
| Spectrum Pharmaceuticals Initiates Phase 3 Study of ZEVALIN[R] in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma (DLBCL); Most Common Form of Aggressive Non-Hodgkin's Lymphoma. |
|
|
Sep 19, 2012 |
1790 |
| NHL & CLL - Diagnosis and Treatment Update. |
|
Disease/Disorder overview |
Aug 23, 2012 |
413 |
| Biovest Conducts End of Phase III Review with FDA of BiovaxID[TM] as Consolidation Therapy in Non-Hodgkin's Lymphoma. |
|
|
Aug 14, 2012 |
1384 |
| Profile of cause of death assigned to adults on antiretroviral therapy in Soweto. |
Karstaedt, A.S. |
Report |
Aug 1, 2012 |
2246 |
| Biovest's BiovaxID[R] Lymphoma Vaccine Featured in FierceBiotech Cancer Immunotherapy Special Report. |
|
|
Jul 18, 2012 |
948 |
| Biovest Initiates Formal Regulatory Approval Process for BiovaxID[R] Cancer Vaccine in Europe. |
|
|
Jun 20, 2012 |
1064 |
| Singapore researchers discover potential new drug to treat deadly cancer. |
|
|
Jun 17, 2012 |
466 |
| Bilateral secondary Non-Hodgkin's Lymphoma of the breasts: a rare case report. |
Das, D.K.; Choudhury, U. |
Clinical report |
Jun 1, 2012 |
1370 |
| Biovest Interviewed by OneMedRadio; Discusses Key Milestones Expected to Establish BiovaxID[R] as the World's First Personalized Cancer Vaccine for the Treatment of Non-Hodgkin's Lymphoma. |
|
|
May 31, 2012 |
846 |
| Millennium and Seattle Genetics Initiate Global Phase 3 Trial of ADCETRIS[TM] in Patients with CD30-Expressing Relapsed Cutaneous T-cell Lymphoma. |
|
|
May 7, 2012 |
1836 |
| Primary NK/T-cell lymphoma of the larynx. |
Uri, Nechama; Schindler, Yaakov; Quitt, Miriam; Valkovsky, Olga; Barzilai, Geva |
Case study |
May 1, 2012 |
1246 |
| Allos Therapeutics Announces Outcome of Request for Re-examination of CHMP Opinion for FOLOTYN[R] in Europe. |
|
|
Apr 20, 2012 |
2234 |
| Millennium Initiates Pivotal Phase 3 Trial of MLN8237 in Patients With Relapsed or Refractory Peripheral T-cell Lymphoma. |
|
|
Mar 6, 2012 |
551 |
| Observational study on treatment of lymphocytic non Hodgkin's lymphoma (CLL) with Viscum album products Helixor P or A: clinical course and safety. |
Gutsch, J.; Rieger, S.; Schlodder, D. |
Report |
Oct 15, 2011 |
510 |
| Non-Hodgkin's lymphoma in a chronic myelocytic leukemia patient treated with imatinib / Imatinib alan bir kronik miyeloid losemi olgusunda gelisen non-Hodgkin lenfoma. |
Paydas, Semra; Duman, Berna Bozkurt; Ergin, Melek |
|
Sep 1, 2011 |
1594 |
| Pixantrone in Combination with Fludarabine, Dexamethasone and Rituximab Produces High Rates of Complete Remissions in Patients with Relapsed or Refractory Indolent Non-Hodgkins Lymphoma. |
|
Clinical report |
Jun 17, 2011 |
951 |
| Data Suggests Treatment with FOLOTYN[R] Reverses Trend of Progressive Resistance Observed in Patients with Drug-Resistant Relapsed or Refractory Peripheral T-Cell Lymphoma. |
|
|
Jun 17, 2011 |
2226 |
| COMPLETE Registry Provides First Glance into Treatment Patterns for Patients with Peripheral T-Cell Lymphoma. |
|
|
Jun 16, 2011 |
1805 |
| Biovest Announces that BiovaxID[R] Personalized Cancer Vaccine is Featured in Journal of Clinical Oncology. |
|
|
Jun 1, 2011 |
1880 |
| Cancer risk nearly 50% higher in RA patients. |
Freeman, Sara |
|
May 1, 2011 |
599 |
| Substitution of Pixantrone for Doxorubicin in CHOP Chemotherapy Regimen Produces High Rates of Complete Remissions and Long-Term Disease Free Survival in Patients with Relapsed/Refractory Aggressive NHL Who Previously Failed Frontline CHOP Therapy. |
|
|
Apr 4, 2011 |
1739 |
| Post-Transplant Lymphoproliferative Disorder Section Integrated into Updated NCCN Guidelines for NHL. |
|
Disease/Disorder overview |
Mar 11, 2011 |
1309 |
| Allos Therapeutics Announces Special Protocol Assessment Agreement with FDA for Phase 3 Trial of FOLOTYN in Patients with Previously Undiagnosed Peripheral T-cell Lymphoma. |
|
|
Mar 3, 2011 |
1946 |
| Belinostat Plus Tarceva[R] Trial in Patients with Non-Small Cell Lung Cancer Enrolls First Patient. |
|
|
Dec 29, 2010 |
1215 |
| Biovest Reports a Significant Discovery in Cancer Vaccines for Lymphoma: Vaccine Isotype Determines Improvement in Disease-Free Survival Following Vaccine Therapy. |
|
|
Dec 6, 2010 |
1542 |
| ZEVALIN Demonstrates 35-Month Progression-Free Survival Benefit after Single Dose in Patients with Non-Hodgkin's Lymphoma. |
|
|
Dec 6, 2010 |
2200 |
| Single Dose ZEVALIN in First-Ever Phase 2 Monotherapy Trial for Non-Hodgkin's Lymphoma Shows Significant and Durable Clinical Responses. |
|
|
Dec 6, 2010 |
1434 |
| New Clinical Data Evaluating ISTODAX[R] in Pivotal Open-Label Phase II Study for Patients with Peripheral T-Cell Lymphoma (PTCL). |
|
|
Dec 5, 2010 |
1248 |
| Allos Therapeutics Reports New Analyses of FOLOTYN[R] Data from PROPEL trial in Relapsed or Refractory Peripheral T-Cell Lymphoma. |
|
|
Dec 4, 2010 |
2939 |
| MALT lymphoma. |
Marcum, Kristin K.; Kemp, E. Shannon; Rees, Catherine J. |
Case study |
Nov 1, 2010 |
367 |
| Differential diagnosis of pediatric tumors of the nasal cavity and paranasal sinuses: a 45-year multi-institutional review. |
Holsinger, F. Christopher; Hafemeister, Adam C.; Hicks, M. John; Sulek, Marcelle; Huh, Winston W.; F |
Report |
Nov 1, 2010 |
3091 |
| Yaupon Announces Positive Results from Pivotal Study of Its Proprietary Topical Mechlorethamine Gel; A Potential Treatment for Early-Stage Cutaneous T-cell Lymphoma. |
|
|
Sep 24, 2010 |
958 |
| BioCryst Reports Results from Two Forodesine Oncology Studies. |
|
Clinical report |
Sep 15, 2010 |
1451 |
| SymBio and Eisai to Launch Symbenda(R) in Singapore for the Treatment of Low-grade Non-Hodgkin's Lymphoma and Chronic Lymphatic Leukemia. |
|
|
Sep 7, 2010 |
667 |
| EMEA Validates Cell Therapeutics, Inc.'s (CTI) Expanded Pixantrone Pediatric Investigation Plan (PIP). |
|
|
Aug 16, 2010 |
1137 |
| Cell Therapeutics, Inc. (CTI) Advances Pixantrone Filing Process in Europe; Submits Expanded Pediatric Investigation Plan (PIP). |
|
|
Jul 6, 2010 |
1138 |
| New Data Confirms the Negative Impact of Febrile Neutropenia in Patients With Non-Hodgkin Lymphoma Receiving R-CHOP Chemotherapy. |
|
|
Jun 14, 2010 |
2264 |
| Micromet's Blinatumomab Induces Durable Remissions in Patients with Relapsed Non-Hodgkin's Lymphoma. |
|
|
Jun 14, 2010 |
1369 |
| Cell Therapeutics Reports New Data Demonstrating That Complete Responses to Pixuvri Are Correlated With Prolonged Survival in Patients With Relapsed or Refractory Aggressive NHL. |
|
|
Jun 11, 2010 |
1420 |
| Allos Therapeutics' FOLOTYN Shows Activity and Tolerability in Phase 1 Dose Finding Study in Patients with Relapsed or Refractory CTCL. |
|
|
Jun 11, 2010 |
1384 |
| Allos Therapeutics Reports New Data Demonstrating that Responses to FOLOTYN are Correlated with Prolonged Survival in Patients with Relapsed or Refractory PTCL. |
|
|
Jun 5, 2010 |
1757 |
| Protocol for the examination of specimens from patients with non-Hodgkin lymphoma/lymphoid neoplasms. |
Hussong, Jerry W.; Arber, Daniel A.; Bradley, Kyle T.; Brown, Michael S.; Chang, Chung-Che "Jeff"; d |
|
Jun 1, 2010 |
6867 |
| Immunohistochemical profile and fluorescence in situ hybridization analysis of diffuse large B-cell lymphoma in Northern China. |
Li, Ting; Medeiros, L. Jeffrey; Lin, Pei; Yin, Hongfang; Littlejohn, Martin; Im, Whan; Lennon, P. Al |
Report |
May 1, 2010 |
4882 |
| Calistoga Pharmaceuticals Initiates Combination Trial of CAL-101 with Rituxan[R] and/or Treanda[R] in Patients with Non-Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia. |
|
|
Apr 7, 2010 |
520 |
| CTI Provides Update on FDA Advisory Committee Meeting on Pixantrone for the Treatment of Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma. |
|
|
Mar 22, 2010 |
781 |
| Levact(R) (bendamustine) Recommended for Approval in Europe for Treating Blood Cancers. |
|
|
Mar 19, 2010 |
537 |
| Non-Hodgkin's lymphoma with bone involvement: a single center experience with 18 patients/ Kemik tutulumlu Hodgkin disi lenfoma: onsekiz hasta ile tek merkez deneyimi. |
Vural, Filiz; Soyer, Nur Akad; Ozen, Pinar; Donmez, Ayhan; Ocakci, Serkan; Saydam, Guray; Cagirgan, |
Report |
Mar 1, 2010 |
2683 |
| Gene Mutations Reveal Potential New Targets for Treating a Type of Non-Hodgkin's Lymphoma. |
|
|
Jan 11, 2010 |
150 |
| Allos Therapeutics' FOLOTYN[TM] Shows Activity in a Dose Finding Phase 1 Study of Relapsed or Refractory Cutaneous T-Cell Lymphoma. |
|
|
Dec 8, 2009 |
1016 |
| The Addition of VELCADE[R] (Bortezomib) for Injection to Novel Combination Delivers Promising Results in Patients with Non-Hodgkin's Lymphoma. |
|
|
Dec 8, 2009 |
1506 |
| Allos Therapeutics' FOLOTYN[TM] Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant. |
|
|
Dec 7, 2009 |
1700 |
| SAR3419 Phase I Study Results in non-Hodgkin's Lymphoma at ASH. |
|
|
Dec 7, 2009 |
1069 |
| Allos Therapeutics Reports New Analyses of Data from Pivotal PROPEL Trial of FOLOTYN[TM] at 51st ASH Annual Meeting. |
|
|
Dec 5, 2009 |
2632 |
| Allos Therapeutics Announces an Agreement with Idis for a Named Patient Program for FOLOTYN[TM] (pralatrexate injection). |
|
|
Dec 4, 2009 |
1180 |
| Allos Therapeutics to Launch Global Registry for Patients with Peripheral T-Cell Lymphoma at the American Society of Hematology Annual Meeting. |
|
|
Dec 3, 2009 |
1259 |
| The diagnostic characteristics of pediatric non-Hodgkin lymphoma patients/ Cocukluk cagi Hodgkin disi lenfomalarinda tanisal ozellikler. |
Sevinir, Betul; Demirkaya, Metin |
Author abstract |
Dec 1, 2009 |
2389 |
| Granulocytic sarcoma of the nasal cavity: a case report. |
Gorman, Mary; Ahmed, Khwaja Asif; Pallera, Arnel; Samant, Sandeep |
Case study |
Nov 1, 2009 |
1654 |
| Malignant lymphoma of the testis: a study of 12 cases. |
Lantz, Andrea G.; Power, Nicholas; Hutton, Brian; Gupta, Rekha |
Clinical report |
Oct 1, 2009 |
3173 |
| Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approval of FOLOTYN[TM] (pralatrexate) for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. |
|
|
Sep 2, 2009 |
1233 |
| Allos Therapeutics Announces FDA Advisory Committee to Review Pralatrexate for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. |
|
|
Aug 10, 2009 |
472 |
| Single Dose Palonosetron Prevents Emesis Induced by Chemotherapy in Non Hodgkin's Lymphoma Patients. |
|
|
Jun 5, 2009 |
1165 |
| Peripheral T-cell lymphomas in HIV-infected individuals: a comprehensive review. |
Castillo, Jorge; Perez, Kimberly; Milani, Cannon; Dezube, Bruce J.; Pantanowitz, Liron |
Clinical report |
Jun 1, 2009 |
5571 |
| The Addition of VELCADE[R] (Bortezomib) for Injection to New and Standard Combinations Delivers Promising Results in Patients with Non-Hodgkin's Lymphoma. |
|
|
May 31, 2009 |
1557 |
| Allos Therapeutics Announces FDA Accepts Pralatrexate NDA for Filing and Grants the Application Priority Review Status. |
|
|
May 26, 2009 |
1128 |
| Pulmonary anaplastic large cell lymphoma--a rare case/Akcigerde anaplastik buyuk hucreli lenfoma-nadir olgu. |
Bingol, Zuleyha; Pihtili, Aylin; Okumus, Gulfer; Kiyan, Esen; Dogan, Oner; Tabak, Levent |
Clinical report |
Mar 1, 2009 |
1539 |
| Allos Therapeutics Announces Final Results from Pivotal PROPEL Trial of Pralatrexate in Patients with Peripheral T-cell Lymphoma. |
|
|
Feb 3, 2009 |
1912 |
| Pediatric follicular lymphoma: a rare clinicopathologic entity. |
Agrawal, Renuka; Wang, Jun |
Clinical report |
Jan 1, 2009 |
3487 |
| ZEVALIN Consolidation in First-Line Therapy in Patients with Non-Hodgkin's Lymphoma Resulted in a Progression-Free Survival of Greater Than 67 Months. |
|
|
Dec 8, 2008 |
1566 |
| Allos Therapeutics Announces Top Line Results from Pivotal Phase 2 PROPEL Trial of Pralatrexate in Patients with Relapsed or Refractory Peripheral T-cell Lymphoma. |
|
Financial report |
Dec 7, 2008 |
2036 |
| Spectrum Pharmaceuticals Announces ZEVALIN sBLA Granted Priority Review by the FDA; Target Decision (PDUFA) Date of April 2, 2009. |
|
|
Dec 1, 2008 |
1638 |
| RECRUITMENT COMPLETED IN OFATUMUMAB NHL PIVOTAL STUDY. |
|
|
Nov 1, 2008 |
390 |
| Biovest and IDIS Announce Agreement to Launch Named-Patient Program for Anti-Cancer Vaccine in Europe. |
|
|
Oct 29, 2008 |
1445 |
| Angiogenic non-Hodgkin T/natural killer (NK)-cell lymphoma: report of three cases. |
Martins-Filho, Rubens A.; Demarco, Ricardo C.; Valera, Fabiana C.P.; Shaletich, Catarina; Felix, Pau |
Clinical report |
Oct 1, 2008 |
2130 |
| Recruitment Completed in Ofatumumab NHL Pivotal Study. |
|
|
Sep 23, 2008 |
683 |
| Radiotherapy-associated euthyroid Graves ophthalmopathy following floor-of-mouth surgery: a case report. |
Jaber, James J.; Thomas, Frank J.; Carfrae, Mathew J.; Galati, Lisa T. |
Clinical report |
Sep 1, 2008 |
2225 |
| Preliminary Results from International Study Report That REVLIMID(R) Provides Responses for Patients with Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma. |
|
Report |
Jun 14, 2008 |
536 |
| Seattle Genetics Reports Final SGN-40 Phase I Non-Hodgkin Lymphoma Data at International Conference on Malignant Lymphoma. |
|
Conference news |
Jun 5, 2008 |
965 |
| Allos Therapeutics Announces Interim Data from Phase 1 Study of PDX in Patients with Relapsed or Refractory Cutaneous T-Cell Lymphoma. |
|
|
Jun 5, 2008 |
1169 |
| Investigational Studies Highlight Potential Utility of Zevalin Radioimmunotherapy in Stem Cell Transplantation for Non-Hodgkin's Lymphoma. |
|
|
Jun 1, 2008 |
604 |
| Gloucester Pharmaceuticals Announces Positive Results from Phase 2b Registration Trial of Romidepsin in Refractory CTCL. |
|
Financial report |
May 19, 2008 |
1047 |
| NCCN Updates Non-Hodgkin's Lymphoma Guidelines. |
|
|
Apr 22, 2008 |
607 |
| Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lymphoma. |
|
|
Apr 22, 2008 |
1317 |
| Therakos, Inc. Receives CE Mark in Europe For Next-Generation Photopheresis System. |
|
|
Apr 14, 2008 |
673 |
| InNexus Biotechnology Announces Second Preclinical CandidateDXL702 (HER2/neu) Targeting Breast Cancer. |
|
|
Feb 19, 2008 |
797 |
| Seattle Genetics Reports Multiple Complete Remissions With SGN-33 in Acute Myeloid Leukemia at ASH. |
|
|
Dec 10, 2007 |
1029 |
| 21. Efficacy and risk estimation of subcutaneous mistletoe treatment (Viscum album L. Pini) in patients with non-Hodgkin's lymphoma. |
Kuehn, J.J. |
|
Oct 1, 2007 |
297 |
| 22. Observation study on treatment with standardized Viscum album extracts (VA-E) in lymphocytic non-Hodgkin lymphoma (CLL): safety and course. |
Gutsch, J.; Rieger, S.; Schierholz, J.M.; Schlodder, D. |
|
Oct 1, 2007 |
486 |
| Genzyme says phase 3 Mozobil trials meet primary endpoints for treating non-Hodgkin's lymphoma, multiple myeloma. |
|
|
Aug 1, 2007 |
474 |
| Radiological case of the month: Vani Vijayakumar, MD; Raman Kansal, MD; and Atiar Rahman, MD, PhD. |
Vijayakumar, Vani; Kansal, Raman; Atiar, Rahman |
Case study |
Jul 1, 2007 |
746 |
| Burkitt's lymphoma of the base of the tongue: a case report and review of the literature. |
Shibuya, Terry Y. |
|
Jun 1, 2007 |
2739 |
| Diosynth Biotechnology Announces Agreement with VGX Pharmaceuticals for Process Development and Clinical Production of VGX-100 for the Treatment of Cancer. |
|
|
May 2, 2007 |
739 |
| Clinical Data Launches PGxPredict(TM):RITUXIMAB on Schedule. |
|
|
Jan 30, 2007 |
1877 |
| Biogen Idec Initiates Phase III Trial of Galiximab for Follicular Non-Hodgkin's Lymphoma. |
|
|
Jan 25, 2007 |
764 |
| Biovest International's Phase 3 Therapy for Follicular Lymphoma Receives Independent Support From Newly Published Phase 2 Trial Data. |
|
|
Oct 19, 2006 |
807 |
| Biovest International Therapy for Follicular Non-Hodgkin's Lymphoma Receives Rare Disease Designation from European Drug Agency. |
|
|
Oct 11, 2006 |
668 |
| Primary B cell lymphoma of the external auditory canal. |
Hersh, David J. |
|
Sep 1, 2006 |
1320 |
| MY 17-YR-OLD BABY GIRL; Cancer dad celebrates IVF success. |
|
|
Aug 29, 2006 |
305 |
| Biovest International Gains Key Regulatory Approval for Clinical Trial Sites in Russia; Biovest to open 14 new clinical sites, accelerating patient recruitment. |
|
|
Jul 18, 2006 |
865 |
| FDA Gives Permission to Use Very Sensitive Molecular Evidence of Cancer in BiovaxID Pivotal Phase 3 Clinical Trial:; Biovest Intends to Use Blood Test to File Application for Accelerated Approval. |
|
|
May 16, 2006 |
1074 |
| Radiological case of the month: Pramod Gupta, MD; Qing Hua Zhao, MD; Mark Rosovsky, MD; Ashok Madan, MD. |
Gupta, Pramod; Zhao, Qing Hua; Rosovsky, Mark; Madan, Ashok |
Case study |
May 1, 2005 |
683 |
| Stem cell transplants for cancer. |
|
|
Apr 1, 2005 |
352 |
| Taking on a lethal blood cancer. |
Seppa, Nathan |
Brief Article |
Jan 1, 2005 |
151 |
| Primary non-Hodgkin's lymphoma of the frontal sinus: case report and review of the literature. |
Butugan, Ossamu |
|
Jan 1, 2005 |
2848 |
| Simultaneous presentation of Hodgkins and follicular non-Hodgkins lymphoma in a previously healthy male. |
Nelson, Douglas A. |
Brief Article |
Oct 1, 2004 |
263 |
| Clinical trial update. |
|
Brief Article |
Jun 1, 2003 |
251 |
| Project aims to track lymphoma outcomes. (Non-Hodgkin's Disease). |
McNamara, Damian |
|
Jan 1, 2003 |
682 |
| Health issues in survivors of childhood cancer. (Featured CME Topic: Pediatrics). |
Hudson, Melissa M. |
|
Sep 1, 2002 |
5084 |
| ONC3 Anemia of cancer in intermediate grade Non-Hodgkin's lymphoma (Ignhl) patients. (Oncology). |
|
Brief Article |
Dec 1, 2001 |
306 |
| CD79[a.sup.+] T-Cell Lymphoblastic Lymphoma With Coexisting Langerhans Cell Histiocytosis: A Short Case Report and Review of the Literature. |
Li, Shiyong; Borowitz, Michael J. |
|
Jul 1, 2001 |
1713 |
| Primary Paratesticular Lymphoma. |
Vega, Francisco; Medeiros, L. Jeffrey; Abruzzo, Lynne V. |
|
Mar 1, 2001 |
2818 |
| An Unusual Variant of Composite Lymphoma. |
Thirumala, Seshadri; Esposito, Michael; Fuchs, Alexander |
|
Sep 1, 2000 |
1821 |
| Bone marrow and peripheral blood hematopoietic stem cell transplantation: focus on autografting. |
Baynes, Roy D.; Hamm, Caroline; Dansey, Roger; Klein, Jared; Cassells, Lucinda; Karanes, Chatchada; |
|
Aug 1, 2000 |
10382 |
